Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 5 - Number 3

Hormonal Contraception in Men

, 5(3): 249 - 257

M. Walton and R. A. Anderson


DOI: 10.2174/1568005310505030249




Signaling Processes in Tumoral Neuroendocrine Pituitary Cells as Potential Targets for Therapeutic Drugs

, 5(3): 259 - 267

M. Paez-Pereda, D. Giacomini, C. Echenique, G. K. Stalla, F. Holsboer and E. Arzt


DOI: 10.2174/1568005310505030259




Caspases as Drug Targets in Ischemic Organ Injury

, 5(3): 269 - 287

S. Faubel and C. L. Edelstein


DOI: 10.2174/1568005310505030269




Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases

, 5(3): 289 - 303

G. Rizzo, B. Renga, A. Mencarelli, R. Pellicciari and S. Fiorucci


DOI: 10.2174/1568005310505030289




Estrogen Receptor Signalling: Bases for Drug Actions

, 5(3): 305 - 314

M. Marino, F. Acconcia and P. Ascenzi


DOI: 10.2174/1568005310505030305




Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases

, 5(3): 315 - 322

S. Miyake and T. Yamamura


DOI: 10.2174/1568005310505030315




From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy: A Detective Story

, 5(3): 323 - 329

T. Miyata, K. Kurokawa and C.van Y. de Strihou


DOI: 10.2174/1568005310505030323




Functional Foods: Salient Features and Clinical Applications

, 5(3): 331 - 337

G. Riezzo, M. Chiloiro and F. Russo


DOI: 10.2174/1568005310505030331




Drug Targets in Colonoscopic Polypectomy: Biological Sealants with Special Reference to Fibrin-Glue (Tissucol)

, 5(3): 339 - 345

P. Venezia


DOI: 10.2174/1568005310505030339




Advances in Osteoclast Differentiation and Function

, 5(3): 347 - 355

Y. Abu-Amer


DOI: 10.2174/1568005310505030347




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science